Nocturnal Breathing and Sleep in Patients With Chronic Obstructive Pulmonary Disease Staying at Altitude
NCT ID: NCT01870830
Last Updated: 2015-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2013-06-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep
NCT02150590
Patients With Chronic Obstructive Pulmonary Disease At Altitude
NCT01875133
Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance
NCT02143609
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep
NCT02150616
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)
NCT06072417
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A: low-intermediate-high altitude
Altitude exposure sequence A, 490-1650-2590m
Altitude exposure
Stay at different altitudes: 490, 1650, 2590 m
B: low-high-intermediate altitude
Altitude exposure sequence B, 490-2590-1650m
Altitude exposure
Stay at different altitudes: 490, 1650, 2590 m
C: intermediate-high-low altitude
Altitude exposure sequence C, 1650-2590-490m
Altitude exposure
Stay at different altitudes: 490, 1650, 2590 m
D: high-intermediate-low altitude
Altitude exposure sequence D, 2590-1650-490m
Altitude exposure
Stay at different altitudes: 490, 1650, 2590 m
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Altitude exposure
Stay at different altitudes: 490, 1650, 2590 m
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* residents at low altitude (\<800 m)
Exclusion Criteria
* Mild (GOLD 1) or very severe COPD (GOLD 4)
* requirement for oxygen therapy at low altitude residence
* hypoventilation
* pulmonary hypertension
* more than mild or unstable cardiovascular disease
* use of drugs that affect respiratory center drive
* internal, neurologic or psychiatric disease that interfere with protocol compliance including current heavy smoking (\>20 cigarettes per day), inability to perform 6 min walk test.
* previous intolerance to moderate altitude (\<2600m).
* Exposure to altitudes \>1500m for \>2 days within the last 4 weeks before the study.
* Pregnant or nursing patients
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Konrad E Bloch, MD
Role: STUDY_CHAIR
University Hsopital Zurich, Switzerland
Tsogyal D Latshang, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Zürich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Pulmonary Division
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Latshang TD, Tardent RPM, Furian M, Flueck D, Segitz SD, Mueller-Mottet S, Kohler M, Ulrich S, Bloch KE. Sleep and breathing disturbances in patients with chronic obstructive pulmonary disease traveling to altitude: a randomized trial. Sleep. 2019 Jan 1;42(1). doi: 10.1093/sleep/zsy203.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-088B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.